In our continued efforts to study the host response to influenza A virus infection, we performed deep sequencing on small RNAs from infected cells and discovered a large population of influenza A virus derived small RNAs mapping to the 5'end of the each of the viral RNA segments. Expression of this small RNA was corroborated by northern blot and required the viral polymerase. Given the known secondary structure of the viral genome, we hypothesized that generation of this small viral RNA (svRNA) would result in disruption of the panhandle and would cause a switch from transcription to replication. As the timing of svRNA production supported this hypothesis, we synthesized svRNA and, upon transfection, observed a decrease in mRNA production, an increase in vRNA synthesis, and a general loss of influenza virus propagation. Furthermore, blocking svRNA availability through competitive hybridization resulted in an increase in mRNA synthesis and complete loss of vRNA. Identification of svRNA answers a very longstanding question as to how influenza A virus switches from transcription to replication and exemplifies a new paradigm for small RNAs and virus infection. Despite determining this putative function for svRNA, how it is generated and the breadth of its activity remains largely unknown. Here we seek to understand these details more thoroughly.
Aim 1 details a strategy to ascertain how each segment-specific svRNA functions.
Aim 2 describes efforts to develop a model for in vitro svRNA synthesis to determine the molecular mechanism by which they are synthesized.
Aim 3 investigates how svRNA affects the host cell environment. The experimental strategy comprising these aims will reveal exciting new molecular targets that can be exploited to generate a novel class of anti-influenza virus therapeutics and will significantly increase our understanding of influenza virus replication.
Greater understanding of influenza virus replication is imperative to control the virus's propensity to cause yearly epidemics and sporadic pandemics. This proposal focuses on the study of a novel small RNA component of the virus in an effort to reveal novel molecular targets for anti-viral design.
|Benitez, Asiel A; Panis, Maryline; Xue, Jia et al. (2015) In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus. Cell Rep 11:1714-26|
|Benitez, Asiel Arturo; Spanko, Laura Adrienne; Bouhaddou, Mehdi et al. (2015) Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response. Cell Rep 13:1456-66|
|Aguado, Lauren C; Schmid, Sonja; Sachs, David et al. (2015) microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection. Cell Host Microbe 18:714-22|
|Heaton, Nicholas S; Langlois, Ryan A; Sachs, David et al. (2014) Long-term survival of influenza virus infected club cells drives immunopathology. J Exp Med 211:1707-14|
|Schmid, Sonja; Zony, Lum C; tenOever, Benjamin R (2014) A versatile RNA vector for delivery of coding and noncoding RNAs. J Virol 88:2333-6|
|Varble, Andrew; Albrecht, Randy A; Backes, Simone et al. (2014) Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe 16:691-700|
|Chua, Mark A; Schmid, Sonja; Perez, Jasmine T et al. (2013) Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep 3:23-9|
|Backes, Simone; Shapiro, Jillian S; Sabin, Leah R et al. (2012) Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host Microbe 12:200-10|
|Perez, Jasmine T; Zlatev, Ivan; Aggarwal, Shilpa et al. (2012) A small-RNA enhancer of viral polymerase activity. J Virol 86:13475-85|